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ABSTRACT 
Objective: To develop and validate new, simple and rapid analytical method for determination of related impurities in isosulfan blue drug 
substances by the liquid chromatographic method as per ICH guidelines. 
Methods: The chromatographic separation obtained between drug substance i.e. isosulfan blue and its related impurities (Impurity-A, Impurity-B 
and Impurity-C) on C18 (100 x 2.00 mm) 1.9µ UPLC column using a mobile phase system containing 0.1 % perchloric acid in water (Mobile phase A) 
and 0.1 % perchloric acid in mixture of 30 volumes of water and 70 volumes of acetonitrile (Mobile Phase B) with gradient program; detector 
wavelength 220 nm and column temperature 30 °C. The developed method was extensively validated according to ICH guidelines. 
Results: Good linearity was observed for isosulfan blue, impurity-A, impurity-B and impurity-C, linearity was calculated from loq Level To 
150%with respect to specification level. The correlation coefficient R = 0.999 was proved and showed that the method is robust. The limit of 
detection of isosulfan blue, impurity-A, impurity-B and impurity-C were found to be 0.010%, 0.015%, 0.030% and 0.0075 % respectively and limit 
of quantitation of isosulfan blue, impurity-A, impurity-B and impurity-C were found to be 0.030%, 0.030%, 0.045% and 0.015% respectively for 2µl 
injection volume. The percentage recovery of isosulfan blue and its related impurities were ranged from 94.0 to 108.0 in bulk drug samples. 
Isosulfan blue sample solution and mobile phase were found to be stable for at least 72 h. The proposed method was found to be suitable and 
accurate for the quantitative determination of impurity-A, impurity-B, impurity-C and other unknown impurities in isosulfan blue drug substances.  
Conclusion: A new, simple and rapid method has been developed and validated for separation and determination of impurity-A, impurity-B, 
impurity-C and unknown impurities of isosulfan blue by the reverse-phase liquid chromatographic method. Analytical method was developed and 
validated as per ICH guidelines.  
The developed method can be used for the quantitative determination of impurity A, impurity B, impurity C and unknown impurities in isosulfan 
blue drug substances in pharmaceutical industry. 
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INTRODUCTION 
Isosulfan blue, having a chemical name, N-[4-[[4-(diethylamino) 
phenyl](2,5-sulfophenyl) methylene]-2,5-cyclohexadien-1-ylidene]-
N-ethylethanaminium,sodium salt [1]. Isosulfan blue is used as a 
cancer diagnostic agent [1]. Other names are sulfan blue or patent 
blue is an active pharmaceutical ingredient (API’s) [2]. 
The chemical formula is C27H31N2NaO6S2; chemical structures show 
in (fig. 1). The chemical structure has been obtained from a process 
for the preparation of isosulfan blue,” U. S. Publication number 
US7534911 [1]. Impurity-A (Des ethyl analogue) is a process related 
impurity, may arise during the manufacturing process of ISO-IV. 
During oxidation of ISO-III this impurity formation is possible, the 
chemical structure shown in (fig. 2). Impurity-B (patent blue) is 
process related impurity. This impurity is patent blue, which is 
isomeric impurity of isosulfan blue, chemical structure show in (fig. 
3). Impurity-C (ISO-III) is process related impurity. This is carryover 
impurity of ISO-III and may arise during the manufacturing process 
of Isosulfan blue, chemical structure show in (fig. 4). 
In the literature, there is no analytical method was reported for 
qualitative and quantitative analysis of Isosulfan blue and its related 
impurities.  
This report describes a reverse-phase ultra-performance liquid 
chromatography method for the rapid separation of impurity A, 
impurity B, impurity C (known impurities) and isosulfan blue on by 
using C18 (100 x 2.00 mm) 1.9µ column. The developed UPLC method 
was validated for quantification of impurity A, impurity B, impurity C 
and unknown impurities in isosulfan blue as per validation of 
analytical procedure guidelines i.e. ICH guideline: Q2(R1) Validation of 
analytical procedures: Text and methodology [6]. 
 
Fig. 1: Chemical structure of isosulfan blue 
 
 
Fig. 2: Chemical structure of impurity-A (Des ethyl analogue) 
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Fig. 3: Chemical structure of impurity-B ((Patent Blue) 
 
 
Fig. 4: Chemical structure of impurity-C (ISO-III) 
 
MATERIALS AND METHODS 
Chromatographic method is developed and validated as per ICH 
guideline [6]. 
Method details are as follows:  
Chemicals 
Isosulfan blue, impurity A, impurity B and impurity C were kindly 
gifted by Emcure Pharmaceuticals Ltd Pune, Maharashtra, India. AR 
grade perchloric acid purchased from JT baker, HPLC grade 
acetonitrile purchased from biosol, AR grade sodium dihydrogen 
phosphate dihydrate purchased from Merck and Millipore water is 
used for mobile phase preparation and diluent preparation. 
Equipment 
Waters Acquity UPLC system with UV and PDA detector and the 
inbuilt auto-injector was utilized for method development and 
validation. Empower2 software was used for data acquisition and 
system suitability calculations. 
Standard preparation 
Weigh accurately about 10 mg of isosulfan blue standard and 15 mg of 
each impurity standard of impurity A, impurity B and impurity C in 
100 ml volumetric flask dissolve in diluents and dilute up to the mark 
(stock solution) further pipette out 10 ml of stock and dilute it to 200 
ml. Further pipette 10 ml above solution in 100 ml volumetric flask. 
Sample preparation  
Weigh accurately and transfer about 25.0 mg of sample in 50 ml 
volumetric flask, dissolve and dilute to volume with diluents.  
Chromatographic conditions (method) 
The chromatographic conditions were optimized using a YMC 
Triart C18 (100 x 2.00 mm) 1.9µ column. The flow rate was set at 
0.35 ml/min. The column was maintained at 30 °C and the 
detection was carried out at a wavelength of 220 nm. The injection 
volume was 2µl. 
Gradient program: Time–mobile phase A,0.0-95, 10.00-30, 15.00-20, 
15.50-95, 17.00-95 
Mobile Phase 
Mobile phase preparation-A 
0.1% perchloric acid in water  
Mobile phase preparation-B 
0.1% perchloric acid in a mixture of 30 volumes of water and 70 
volumes of acetonitrile.  
Diluent Preparation 
10 mmol of sodium dihydrogen phosphate dihydrate water.  
Validation of the method  
Specificity 
Specificity study was carried out to verify there is no any blank 
interference with respect to the peak of interest, all the peaks are 
separated properly and peak purity of all individual peaks are complying 
typical ultra-performance liquid chromatography chromatogram 
showed in (fig. 5). The results are tabulated in (table 1). 
 
 
Fig. 5: Typical ultra-performance liquid chromatography chromatogram with data of system suitability (standard) 
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Table 1: System-suitability (specificity) report 
 Compound  Rt RS N T  
Impurity-C 2.74 - 21406 1.18 
 Impurity-A 5.75 39.24 90910 1.36 
Isosulfan Blue 6.52 9.54 100761 1.38 
Impurity-B 7.80 13.98 119938 1.48 
RS–USP resolution, N-number of theoretical plates (USP tangent method), T-USP tailing factor 
 
Forced degradation 
As part of specificity study, product was subjected for degradation 
under different conditions like acidic, basic, oxidation, thermal, 
photolytic, humidity conditions. In Degradation study, it is ensured 
that all the peaks are separated and complying for peak purity.  
Limit of detection and quantitation 
The lower concentration levels of analyte i.e. isosulfan blue and its 
related impurities prepared and injected. The limit of detection, limit 
of quantitation values have been determined from signal to noise 
ratio and are tabulated in (table 2).  
 
Table 2: Limit of detection and limit of quantitation 
Compound LOD (%) w. r. t-test LOQ (%) w. r. t-test 
Isosulfan Blue 0.010 0.030 
Impurity-A 0.015 0.030 
Impurity-B 0.030 0.045 
Impurity-C 0.0075 0.015 
LOD-Limit of detection, LOQ-Limit of quantitation 
 
Limit of quantitation precision 
For the limit of quantitation precision study, six replicate injections 
of isosulfan blue and known impurities at the limit of quantitation 
concentration were injected. Percent relative standard deviation for 
the peak area of isosulfan blue, known impurities and signal to noise 
ratio was evaluated [6].  
Linearity and range 
Linearity was calculated from limit of quantitation level to 150 % 
with respect to specification level for isosulfan blue, impurity A, 
impurity B and impurity C. The range was selected from limit of 
quantitation, 50%, 80%, 100%, 120% to 150% of specification limit for 
impurity A, impurity B, impurity C, and isosulfan blue (For any 
unspecified unidentified impurity). 
Precision  
System precision 
Blank solutions and six replicate injections of standard solution 
were injected as per methodology. Percent relative standard 
deviation of area obtained from six replicate injections of standard 
solution was calculated. Results are tabulated in (table 3). 
 
Table 3: System precision results 
Compound Relative standard 
deviation in percent 
Isosulfan blue 1.7 
Impurity A 0.8 
Impurity B 3.1 
Impurity C 0.9 
Method precision 
Method precision was demonstrated by spiking the known 
impurities at specification level in the sample. One unspiked 
sample and six different samples of the same batch spiked with 
known impurities were prepared and analyzed as per 
methodology. Calculated percent impurity level and relative 
standard deviation for isosulfan blue and impurities. Results are 
tabulated in (table 4). 
Intermediate precision 
The similar procedure of method precision was carried out by 
the different analyst, on different day, on a different instrument, 
by different column lot number using the same sample used in 
method precision as per methodology. Percent relative standard 
deviation of results was calculated.  
Overall percent relative standard deviation of method precision 
and intermediate precision results was also calculated. The 
tabulated data shows that the analyst first has done the method 
precision and analyst second has done the intermediate 
precision. Results are tabulated in (table 5). 
Accuracy (Recovery) 
The recovery level solutions were prepared by spiking impurity A, 
impurity B and impurity C at the limit of quantitation, 50%, 100% 
and 150% of the specification level in the sample. Two preparations 
of each level were made and injected as per methodology % 
Recovery mean recovery and % relative standard deviation 
calculated. Results are tabulated in (table 6). 
 
Table 4: Method precision results 
Method precision: (n=6) 
Compound Mean (%) RSD (%) 
Impurity-A 0.1639 0.73 
Impurity-B 0.1444 1.65 
Impurity-C 0.1563 0.64 
Any unspecified unidentified impurity (Highest) 0.0122 NA 
Total impurities 0.4768 0.79 
RSD-Relative standard deviation, n-Number of injection, NA-Not applicable 
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Table 5: Intermediate precision results 
Intermediate precision: (n=6) 
Compound Mean (%) RSD (%) 
Impurity-A 0.1664 0.73 
Impurity-B 0.1426 1.00 
Impurity-C 0.1579 0.79 
Any unspecified unidentified impurity(Highest) 0.0115 NA 
Total impurities 0.4784 0.34 
Overall relative standard deviation of method precision and intermediate precision results (n=12) 
Compound Mean (%) Overall RSD (%) 
Impurity-A 0.1652 1.05 
Impurity-B 0.1435 1.46 
Impurity-C 0.1571 0.87 
Any unspecified unidentified impurity(Highest) 0.0118 NA 
Total impurities 0.4776 0.60 
RSD-Relative standard deviation, n-Number of injection, NA-Not applicable. 
 
Table 6: Accuracy (Recovery) results 
Level/Impurity Impurity-A Impurity-B Impurity-C 
LOQ Mean % Recovery 103.67 107.52 108.38 
RSD (%) 2.40 2.88 4.60 
50% Mean Recovery (%) 96.86 101.96 95.56 
RSD (%) 0.66 3.70 0.28 
100% Mean Recovery (%) 94.53 99.26 95.04 
RSD (%) 0.69 1.90 0.31 
150% Mean Recovery (%) 94.22 96.99 94.72 
RSD (%) 0.98 1.81 0.37 
 RSD-Relative standard deviation, LOQ-Limit of quantitation 
 
Solution stability 
Solution stability was performed at room temperature. Standard 
preparation, the test sample and spiked test preparation with 
known impurities at specification level and injected at 
0,6,12.18,24,36,48,72 hourly basis.  
Robustness 
Robustness of the method was verified by deliberately varying the 
instrumental conditions such as by changing flow rate ± 10% (Flow= 
0.385 ml/min and 0.315 ml/min). By changing column oven 
temperature ± 5 °C (Temperature 35 °C and 25 °C) and by changing 
column lot number. The system suitability was evaluated in each 
condition, and the spiked sample was analyzed in triplicate.  
RESULTS AND DISCUSSION 
An analytical method has been developed and validated as per ICH 
guideline for drug substance isosulfan blue. All the validation 
parameters are studied and results found within guideline 
requirements. The details are as follows:  
Specificity 
The peak due to isosulfan blue is well resolved from peak due to its 
known impurities. The blank does not show any peak at the 
retention time of isosulfan blue and its known impurities. Peak 
purity angle is less than peak purity threshold which implies that 
peak purity passes. Hence it is concluded that method is selective. 
Forced degradation 
Peak due to isosulfan blue and degradation product are well 
separated. The peak purity of isosulfan blue in degraded and as such 
sample found complying as per ICH guideline.  
Limit of detection and quantitation 
Percent relative standard deviation of the limit of quantitation 
precision was well within acceptance criteria and found. Below 10%. 
Hence it is concluded that the method can quantify, reported a limit 
of quantitation precision with precision. 
Linearity and range 
The straight-line nature of graph and correlation coefficient was 
well within the acceptance criteria and found more than 0.99. It 
shows that method has linearity from the limit of quantitation to 
150% of specification limit for impurity-A, impurity-B, impurity-C, 
and isosulfan blue (for any unspecified unidentified impurity). 
Precision 
Percent relative standard deviation of area obtained from six replicate 
injections of standard solution is below 5%. Hence the system is precise 
for determination of related substances in isosulfan blue. 
Method precision 
Relative standard deviation of % impurity A, % impurity B, % 
impurity C, % any unspecified unidentified impurity, % total 
impurities obtained from six different spiked test preparations 
found below 5%. Hence it is concluded that the method is precise for 
the determination of related substances in isosulfan blue. 
Intermediate precision 
Relative standard deviation of % impurity A, % impurity B, % 
impurity C, % any unspecified unidentified impurity, % total 
impurities obtained from six different spiked test preparations 
found below 5%. Overall percent relative standard deviation of 
method precision and intermediate precision results is below 5% 
criteria. It shows that there is no effect of random events on the 
precision of analytical procedure. 
Accuracy (Recovery) 
The recovery data is well within the acceptance criteria. Recovery 
obtained for impurity A, impurity B and impurity C between 80% to 
120%. It shows that method is accurate for determination of related 
substances in isosulfan blue 
Solution stability 
Standard preparation and sample preparation found stable up to 
72 h. 
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Robustness 
The system suitability was evaluated in each condition and the 
spiked sample was analyzed in triplicate. The results are 
compared with the method precision by calculating overall 
percent relative standard deviation and found below 5%. The 
peak due to isosulfan blue is well resolved from peak due to its 
known impurities. 
CONCLUSION  
A new, simple and rapid method is developed and validated as 
per ICH guideline for separation and determination of impurity 
A, impurity B, impurity C and unknown impurities of isosulfan 
blue drug substances by UPLC. The method validation was 
carried out by using YMC Triart C18 (100 x 2.00 mm) 1.9 µ 
columns. The developed method can be used for the quantitative 
determination of impurity A, impurity B, impurity C and 
unknown impurities of isosulfan blue drug substances in 
pharmaceutical industry. 
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